Skip to main content

Aspekte zur Therapie der akuten Schizophrenie unter besonderer Berücksichtigung von Zuclopenthixol

  • Chapter
Thioxanthene

Zusammenfassung

Die heutige antipsychotische Therapie ist gekennzeichnet durch eine vergleichsweise kurze stationäre Behandlung, gefolgt von einer ambulanten Nachsorge. Die chronische Schizophrenie ist im allgemeinen eine rezidivierende Erkrankung, doch dauert in vielen Fällen auch die akut psychotische Phase relativ lange an. Daraus ergibt sich das Risiko, daß solche Patienten nach der Entlassung einen Rückfall erleiden, wenn sie ihre antipsychotische Medikation nicht fortführen. Dies wiederum macht den Wunsch verständlich, auch in der akuten oder subakuten Phase der Psychose die Einhaltung der medikamentösen Therapie sicherzustellen, etwa durch Injektion einer Depotform.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amdisen A, Aaes-Jorgensen T, Thomsen NJ, Madsen VT, Nielsen MS (1986) Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Yiscoleo. Psychopharmacology 90: 412–416

    Article  PubMed  CAS  Google Scholar 

  • Amdisen A, Nielsen MS, Deneker SJ et al. (1987) Zuclopenthixol acetate in Viscoleo - a new drug formulation. Acta Psychiatr Scand 75: 99–107

    Article  PubMed  CAS  Google Scholar 

  • Balant LP, Balant-Gorgea AE, Eisele R, Reith B, Gex-Fabry M, Garone G (submitted for publication) Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo. Pharmacopsychiatry

    Google Scholar 

  • Bech P, Bolwig TG, Kramp P, Rafaelsen OJ (1979) The Bech-Rafaelsen mania scale and the Hamilton depression scale. Acta Psychiatr Scand 59: 420–430

    Article  PubMed  CAS  Google Scholar 

  • Bech P, Kastrup M, Rafaelsen OJ (1986) Mini-compendium of rating scales for status of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 73 [Suppl 326]: 32–37

    Article  Google Scholar 

  • Deneker SJ (1986) Clinical experience with zuclopenthixol acetate. In: Rafaelsen OJ, Christensen AV (eds) What can basic biological psychiatry do for the treatment of acute psychosis? (Regional symposium, World Psychiatric Association, Copenhagen, Denmark, pp 77–92 )

    Google Scholar 

  • Deneker SJ, Malm U (1984) Combination of neuroleptics and psychosocial therapies in schizophrenia. Nord J Psychiatry 38: 27–30

    Article  Google Scholar 

  • Deneker SJ, May PRA (1986) The treatment of acute psychosis. Lundbeck, Kopenhagen Deneker SJ, Malm U, Jorgensen A, Fredricson Overo K (1980) Clopenthixol and flupentixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome. Acta Psychiatr Scand 61 [Suppl 279]: 55–63

    Article  Google Scholar 

  • Guy W (1976) ECDEU assessment manual for psychopharmacology. DHEW Publication No (ADM), National Institute of Mental Health, Rocheville, MD, pp 76–338

    Google Scholar 

  • Jorgensen A, Fredricsen Overo K (1980) Clopenthixol and flupentixol depot preparations in outpatient schizophrenics. III. Serum levels. Acta Psychiatr Scand 61 [Suppl 279]–41-54

    Google Scholar 

  • Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Eigen K (1987) The UKU side effet rating scale. Acta Psychiatr Scand 76 [Suppl 334]: 81–95

    Article  Google Scholar 

  • Neborsky R, Janowsky D, Munson E, Depry D (1981) Rapid treatment of acute psychotic symptoms with high and low doses haloperidol. Arch Gen Psychiatry 38: 195–199

    PubMed  CAS  Google Scholar 

  • Pedersen Y, Sleth Nielsen M et al. (1987) An open multicentre study of zuclopenthixol acetate 5 per cent in Viscoleo in acute psychoses including mania. Lundbeck, Kopenhagen (intern report )

    Google Scholar 

  • Tuason VB (1986) A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients. J Clin Psychiatry 47: 126–129

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dencker, S.J. (1990). Aspekte zur Therapie der akuten Schizophrenie unter besonderer Berücksichtigung von Zuclopenthixol. In: Müller-Oerlinghausen, B., Möller, HJ., Rüther, E. (eds) Thioxanthene. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75194-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75194-3_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-51847-1

  • Online ISBN: 978-3-642-75194-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics